Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A second buffer dose ranging study of LTX-03

Next Previous
X
Search
Trial Profile

A second buffer dose ranging study of LTX-03

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 13 Oct 2017

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Hydrocodone/paracetamol (Primary)
  • Indications Pain
  • Focus Adverse reactions

    • Most Recent Events

    • 13 Oct 2017 New trial record
    • 09 Oct 2017 This study is expected to commence in the 4Q 2017 with topline results in the 1Q 2018, as reported in an Acura Pharmaceuticals. The Company expects to complete this next study in the first quarter of 2018.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top